Central City Dialysis is a medicare approved dialysis facility center in El Paso, Texas and it has 28 dialysis stations. It is located in El Paso county at 1310 Murchison Drive, El Paso, TX, 79902. You can reach out to the office of Central City Dialysis at (915) 533-0011. This dialysis clinic is managed and/or owned by Davita. Central City Dialysis has the following ownership type - Profit. It was first certified by medicare in February, 1993. The medicare id for this facility is 452651 and it accepts patients under medicare ESRD program.
| Name | Central City Dialysis |
|---|---|
| Location | 1310 Murchison Drive, El Paso, Texas |
| No. of Dialysis Stations | 28 |
| Medicare ID | 452651 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 1310 Murchison Drive, El Paso, Texas, 79902 | |
| (915) 533-0011 | |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
| NPI Number | 1972566040 |
| Organization Name | Central City Dialysis |
| Doing Business As | Total Renal Care Texas Limited Partnership |
| Address | 1310 Murchison Dr El Paso, Texas, 79902 |
| Phone Number | (915) 533-8503 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 79% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 14% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 7% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 77% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 0% | 14% |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 69% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 19% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 12% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 76% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 19% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 88% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 12% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 81% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 5% | 12% |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 43 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 7 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 105 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 997 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Central City Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 108 |
| Hypercalcemia patient months | 1012 |
| Patients with Serumphosphor | 119 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 36 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 13 |
| Patients with Serumphosphor greater than 7 mg/dL | 8 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 88 |
| Patient months included in arterial venous fistula and catheter summaries | 554 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 60 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 4 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 86 |
| Hospitalization Rate in facility | 170.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 294.9 |
| Hospitalization Rate: Lower Confidence Limit | 101.6 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Central City Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 31.5 |
| Readmission Rate: Lower Confidence Limit | 11.3 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Central City Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .95 (As Expected) |
| SIR: Upper Confidence Limit | 2.1 |
| SIR: Lower Confidence Limit | .35 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Central City Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 79 |
| Transfusion Rate in facility | 26 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 72 |
| Transfusion Rate: Lower Confidence Limit | 10.6 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Central City Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 494 |
| Mortality Rate in facility | 18.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24 |
| Mortality Rate: Lower Confidence Limit | 14.2 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago
Fresenius Medical Care El Paso Gateway Location: 10767 Gateway West, El Paso, Texas, 79935 Phone: (915) 599-2891 |
Fresenius Medical Care Cliffview Location: 1225 E Cliff Drive, El Paso, Texas, 79902 Phone: (915) 532-6411 |
News Archive
Romark Laboratories announced that results of a large Phase 2B-3 US clinical trial of its new flu drug, NT-300 (nitazoxanide), will be presented as an oral late-breaking communication at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA) being held in Boston, October 20-23, 2011.
It's a GEMM of a system. Genetically engineered mouse models that is. Using them allows scientists to study cancer in a way that more naturally mimics how human tumors exist within the complex environment of the body.
Many people want to keep driving after having a stroke, and many can do so safely. Simple tests in the office can help doctors determine who is more likely to be a safe driver after a stroke, according to research published in the February 22, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
A prominent House committee will continue its case against the healthcare law just one day after the conclusion of August recess. On Sept. 11, the Ways and Means Subcommittee on Oversight will look at how the law's implementation could strain the Internal Revenue Service.
› Verified 1 days ago